Director/PDMR Shareholding

Oxford Biomedica PLC 30 April 2007 Oxford BioMedica plc (the 'Company') Director Shareholdings The Company received notification on 27 April 2007 that, on that day, Dr. Susan Kingsman, a director of the Company and wife of Professor Alan Kingsman, Chief Executive Officer of the Company, sold 4,000,000 ordinary shares of 1p each in the Company ('Ordinary Shares') at 48 pence per share. Following this transaction, Dr. Kingsman is interested in 13,032,590 Ordinary Shares representing 2.44 per cent. of the Company's issued share capital. This includes 8,293,451 Ordinary Shares held by Professor Alan Kingsman, 210,000 Ordinary Shares held jointly by Alan and Susan Kingsman and 100,000 Ordinary Shares held by the son of Alan and Susan Kingsman. In addition, Andrew Wood and Peter Nolan, both Directors of the Company, have today exercised options over 167,000 and 132,000 Ordinary Shares in the Company respectively. Both directors have subsequently sold all of these Ordinary Shares for 48 pence per share. These shares were placed by Evolution Securities with institutional investors. Following these transactions, the total interests of Andrew Wood and Peter Nolan in the Company's Ordinary Shares and share options are as follows: +-----------------------+----------------------+-----------------------------+ | |Ordinary Shares |Share Options | +-----------------------+----------------------+-----------------------------+ |Andrew Wood |205,067 |1,428,923 | +-----------------------+----------------------+-----------------------------+ |Peter Nolan |163,638 |906,162 | +-----------------------+----------------------+-----------------------------+ The exercise price for the options exercised today was 19.25p per share. The newly allotted shares are subject to a block listing, so are already listed. Including these shares, the total number of the Ordinary Shares in issue is now 533,939,015. 30 April 2007 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings